Jeffrey Chodakewitz
CIK 1610876 · EVP GMDA, CMO · last filed 2026-06-23
Jeffrey Chodakewitz is an EVP GMDA, CMO who has filed 65 SEC Form 4 insider transactions across 7 companies since 2014. The most recent filing, for ACET, was dated Jun 23, 2026. Across all open-market trades the lifetime net is −$30.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $36.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$36.30M
7
65
-$30.85M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACET | Director | 1,106 | $8.20 | $9.1K | $0 | 8 | 2026-06-23 |
| SDGR | Director | 25,388 | $15.29 | $388.2K | $0 | 7 | 2026-06-23 |
| PRAX | Director | 1,371 | $295.81 | $405.6K | $0 | 6 | 2026-06-12 |
| NCNA | Director | — | $1.29 | — | $0 | 1 | 2024-08-23 |
| Adicet Bio, Inc. (TORC) Delisted | Director | — | — | — | $0 | 3 | 2020-06-05 |
| TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | Director | — | — | — | $0 | 5 | 2019-06-11 |
| VRTX | EVP GMDA, CMO | 72,385 | $490.39 | $35.50M | -$30.85M | 35 | 2018-02-14 |
Recent Filings
65 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-23 | ACET | Grant (A) | — | $0 | EDGAR |
| 2026-06-23 | SDGR | Grant (A) | +8,141 | $0 | EDGAR |
| 2026-06-12 | PRAX | Grant (A) | +1,371 | $0 | EDGAR |
| 2025-06-27 | PRAX | Grant (A) | — | $0 | EDGAR |
| 2025-06-20 | SDGR | Grant (A) | +5,997 | $0 | EDGAR |
| 2025-06-13 | ACET | Grant (A) | +5,900 | $0 | EDGAR |
| 2024-08-23 | NCNA | Mixed | — | $0 | EDGAR |
| 2024-06-20 | SDGR | Grant (A) | +5,000 | $0 | EDGAR |
| 2024-06-07 | ACET | Grant (A) | +5,900 | $0 | EDGAR |
| 2024-06-06 | PRAX | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.